COVID-19 Vaccine |
1 |
1 |
Vaccines |
0 |
0.93 |
COVID-19 |
0 |
0.79 |
Severe Acute Respiratory Syndrome |
0 |
0.77 |
Biologic Therapy |
0 |
0.61 |
Pandemic |
0 |
0.99 |
Antigens |
0 |
0.26 |
Dorsum |
0 |
0.26 |
Outbreak |
0 |
0.26 |
Acute Respiratory Distress Syndrome |
0 |
0.17 |
Diversity |
0 |
0.17 |
Hospital |
0 |
0.17 |
Allergy |
0 |
0.09 |
Biomedical Technology |
0 |
0.09 |
Face |
0 |
0.09 |
Genetics |
0 |
0.09 |
Jobs |
0 |
0.09 |
Massachusetts |
0 |
0.09 |
Nasopharyngitis |
0 |
0.09 |
Nevus |
0 |
0.09 |
Receptors |
0 |
0.09 |
Students |
0 |
0.09 |
T-Lymphocyte |
0 |
0.09 |
Wisconsin |
0 |
0.09 |
Otolaryngology |
0 |
0.05 |
Social Determinants of Health |
0 |
0.04 |
Medical Life |
0 |
0.03 |
Genomic Medicine |
0 |
0.02 |